These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7962424)

  • 1. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.
    Schoot DC; Harlin J; Shoham Z; Mannaerts BM; Lahlou N; Bouchard P; Bennink HJ; Fauser BC
    Hum Reprod; 1994 Jul; 9(7):1237-42. PubMed ID: 7962424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism.
    Shoham Z; Mannaerts B; Insler V; Coelingh-Bennink H
    Fertil Steril; 1993 Apr; 59(4):738-42. PubMed ID: 8458489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
    J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
    van Heusden AM; Coelingh Bennink HJ; Fauser BC
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
    Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.
    Hohmann FP; Laven JS; de Jong FH; Eijkemans MJ; Fauser BC
    Hum Reprod; 2001 May; 16(5):846-54. PubMed ID: 11331627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
    Mannaerts B; Fauser B; Lahlou N; Harlin J; Shoham Z; Bennink HC; Bouchard P
    Fertil Steril; 1996 Feb; 65(2):406-10. PubMed ID: 8566271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP; Laven JS; de Jong FH; Fauser BC
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development.
    Welt CK; Smith ZA; Pauler DK; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2531-7. PubMed ID: 11397851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary.
    Smyth CD; Miró F; Howles CM; Hillier SG
    Hum Reprod; 1995 Jan; 10(1):33-9. PubMed ID: 7745066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
    Bry-Gauillard H; Larrat-Ledoux F; Levaillant JM; Massin N; Maione L; Beau I; Binart N; Chanson P; Brailly-Tabard S; Hall JE; Young J
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1102-1111. PubMed ID: 28324034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.
    Eldar-Geva T; Robertson DM; Cahir N; Groome N; Gabbe MP; Maclachlan V; Healy DL
    J Clin Endocrinol Metab; 2000 Feb; 85(2):607-13. PubMed ID: 10690863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
    Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.